These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 32506110)
1. Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences. Nasir M; Talha KA; Islam T; Saha SK; Selina F; Parveen RA Mymensingh Med J; 2020 Apr; 29(2):481-487. PubMed ID: 32506110 [TBL] [Abstract][Full Text] [Related]
2. Rapid review for the anti-coronavirus effect of remdesivir. Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648 [TBL] [Abstract][Full Text] [Related]
3. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812 [TBL] [Abstract][Full Text] [Related]
4. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Singh AK; Singh A; Singh R; Misra A Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865 [TBL] [Abstract][Full Text] [Related]
5. Use of remdesivir for patients with Covid-19: a review article. Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862 [TBL] [Abstract][Full Text] [Related]
6. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
7. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
8. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
10. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959 [TBL] [Abstract][Full Text] [Related]
11. Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature. Musa A; Pendi K; Hashemi A; Warbasse E; Kouyoumjian S; Yousif J; Blodget E; Stevens S; Aly B; Baron DA West J Emerg Med; 2020 May; 21(4):737-741. PubMed ID: 32726230 [TBL] [Abstract][Full Text] [Related]
12. Compassionate Use of Remdesivir for Patients with Severe Covid-19. Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812 [TBL] [Abstract][Full Text] [Related]
13. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Cao YC; Deng QX; Dai SX Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927 [TBL] [Abstract][Full Text] [Related]
14. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM; JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Trials; 2020 May; 21(1):422. PubMed ID: 32448345 [TBL] [Abstract][Full Text] [Related]
16. Remdesivir for severe covid-19: a clinical practice guideline. Rochwerg B; Agarwal A; Zeng L; Leo YS; Appiah JA; Agoritsas T; Bartoszko J; Brignardello-Petersen R; Ergan B; Ge L; Geduld H; Gershengorn HB; Manai H; Huang M; Lamontagne F; Kanda S; Kawano-Dourado L; Kurian L; Kwizera A; Murthy S; Qadir N; Siemieniuk R; Silvestre MA; Vandvik PO; Ye Z; Zeraatkar D; Guyatt G BMJ; 2020 Jul; 370():m2924. PubMed ID: 32732352 [TBL] [Abstract][Full Text] [Related]
17. Case report study of the first five COVID-19 patients treated with remdesivir in France. Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764 [TBL] [Abstract][Full Text] [Related]
19. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. Sun D AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279 [TBL] [Abstract][Full Text] [Related]
20. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment. Khazir J; Maqbool T; Mir BA Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]